Commentary: We need to know more about erythropoietin
- PMID: 34317996
- PMCID: PMC8302981
- DOI: 10.1016/j.xjtc.2020.07.024
Commentary: We need to know more about erythropoietin
Comment on
-
Arterial and venous thrombosis complicating coronary artery bypass grafting after use of epoetin alfa-epbx.JTCVS Tech. 2020 Dec;4:154-155. doi: 10.1016/j.xjtc.2020.07.018. Epub 2020 Aug 4. JTCVS Tech. 2020. PMID: 32838336 Free PMC article. No abstract available.
References
-
- D'Ambra M.N., Hillman R., Jones J., Kim H.C., Rawitscher R., Schnaper H., et al. The effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg. 1997;64:1686–1693. - PubMed
-
- Tanaka A., Ota T., Uriel N., Asfaw Z., Onsager D., Lonchyna V.A., et al. Cardiovascular surgery in Jehovah's witness patients: the role of preoperative optimization. J Thorac Cardiovasc Surg. 2015;150:976–983. - PubMed
-
- D'Ambra M.N., FitzGerald D., Kaufman R.M., Shekar P. Blood conservation: why aren't we doing this for everyone? J Thorac Cardiovasc Surg. 2015;150:984–985. - PubMed
-
- Society of Thoracic Surgeons Blood Conservation Guideline Task Force. Ferraris V.A., Brown J.R., Despotis G.J., Hammon J.W., Reece T.B., et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944–982. - PubMed
Publication types
LinkOut - more resources
Full Text Sources